These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 9264574

  • 1. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM.
    Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S.
    N Engl J Med; 1999 Apr 15; 340(15):1144-53. PubMed ID: 10202165
    [Abstract] [Full Text] [Related]

  • 4. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 15; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 5. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Dec 15; 103(3):1038-42. PubMed ID: 16889823
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trials.
    Calkins AR, Harrison CR, Fowler WC, Gallion H, Mangan CE, Husseinzadeh N, Alvarez RD, Mychalczak B, Podczaski E.
    Gynecol Oncol; 1999 Dec 15; 75(3):349-55. PubMed ID: 10600288
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S, Gynecologic Oncology Group.
    J Clin Oncol; 2007 Jul 01; 25(19):2804-10. PubMed ID: 17502627
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
    Vokes EE, Haraf DJ, Brockstein BE, Weichselbaum RR.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):70-6. PubMed ID: 10210543
    [Abstract] [Full Text] [Related]

  • 9. Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
    Mundt AJ, Rotmensch J, Waggoner S, Quiet C, Fleming G.
    Gynecol Oncol; 1999 Jan 01; 72(1):45-50. PubMed ID: 9889028
    [Abstract] [Full Text] [Related]

  • 10. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 01; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 11. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M, Cowen D, Viens P, Noirclerc M, Perez T, Gouvernet J, Delpero JR, Gamerre M, Boubli L, Houvenaeghel G.
    Gynecol Oncol; 1994 Jul 01; 54(1):68-75. PubMed ID: 8020842
    [Abstract] [Full Text] [Related]

  • 12. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.
    Gynecol Oncol; 2005 Apr 01; 97(1):126-35. PubMed ID: 15790448
    [Abstract] [Full Text] [Related]

  • 13. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
    Husseinzadeh N, Shrake P, DeEulis T, Rowley K, Aron B.
    Gynecol Oncol; 1994 Mar 01; 52(3):326-31. PubMed ID: 8157190
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY, Blessing JA, Valea FA, McGehee R, Manetta A, Webster KD, Andersen WA.
    Gynecol Oncol; 1997 Dec 01; 67(3):255-8. PubMed ID: 9441772
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan 01; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 17. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.
    N Engl J Med; 1999 Apr 15; 340(15):1137-43. PubMed ID: 10202164
    [Abstract] [Full Text] [Related]

  • 18. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Apr 15; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 19. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 20. Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
    Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S, Ishigaki T.
    Gynecol Oncol; 2006 Sep 01; 102(3):493-9. PubMed ID: 16478629
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.